201 related articles for article (PubMed ID: 29772075)
1. CD6 monoclonal antibodies differ in epitope, kinetics and mechanism of action.
Garner LI; Hartland A; Breuning J; Brown MH
Immunology; 2018 Oct; 155(2):273-282. PubMed ID: 29772075
[TBL] [Abstract][Full Text] [Related]
2. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
[TBL] [Abstract][Full Text] [Related]
3. Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction.
Chappell PE; Garner LI; Yan J; Metcalfe C; Hatherley D; Johnson S; Robinson CV; Lea SM; Brown MH
Structure; 2015 Aug; 23(8):1426-1436. PubMed ID: 26146185
[TBL] [Abstract][Full Text] [Related]
4. The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation.
Osorio LM; Garcia CA; Jondal M; Chow SC
Cell Immunol; 1994 Mar; 154(1):123-33. PubMed ID: 7509726
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab.
Hernández P; Moreno E; Aira LE; Rodríguez PC
Curr Drug Targets; 2016; 17(6):666-77. PubMed ID: 26844560
[TBL] [Abstract][Full Text] [Related]
6. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
[TBL] [Abstract][Full Text] [Related]
7. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein.
Bott CM; Doshi JB; Morimoto C; Romain PL; Fox DA
Int Immunol; 1993 Jul; 5(7):783-92. PubMed ID: 7690243
[TBL] [Abstract][Full Text] [Related]
8. Domain-specific CD6 monoclonal antibodies identify CD6 isoforms generated by alternative-splicing.
Santos RF; Oliveira L; Brown MH; Carmo AM
Immunology; 2019 Aug; 157(4):296-303. PubMed ID: 31162836
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the CD6 ligand binding domain.
Skonier JE; Bodian DL; Emswiler J; Bowen MA; Aruffo A; Bajorath J
Protein Eng; 1997 Aug; 10(8):943-7. PubMed ID: 9415444
[TBL] [Abstract][Full Text] [Related]
10. Human CD6 possesses a large, alternatively spliced cytoplasmic domain.
Robinson WH; Neuman de Vegvar HE; Prohaska SS; Rhee JW; Parnes JR
Eur J Immunol; 1995 Oct; 25(10):2765-9. PubMed ID: 7589069
[TBL] [Abstract][Full Text] [Related]
11. Cell surface receptors and their ligands: in vitro analysis of CD6-CD166 interactions.
Bowen MA; Aruffo AA; Bajorath J
Proteins; 2000 Aug; 40(3):420-8. PubMed ID: 10861932
[TBL] [Abstract][Full Text] [Related]
12. Analyses of monoclonal antibodies reactive with porcine CD6.
Saalmüller A; Aasted B; Canals A; Dominguez J; Goldman T; Lunney JK; Maurer S; Pauly T; Pescovitz MD; Pospisil R
Vet Immunol Immunopathol; 1994 Oct; 43(1-3):243-7. PubMed ID: 7531907
[TBL] [Abstract][Full Text] [Related]
13. Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).
Le Dantec C; Alonso R; Fali T; Montero E; Devauchelle V; Saraux A; Pers JO; Renaudineau Y
Immunol Res; 2013 Jul; 56(2-3):341-7. PubMed ID: 23576060
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
[TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of a novel CD6 ligand in cells derived from joint and epithelial tissues.
Saifullah MK; Fox DA; Sarkar S; Abidi SM; Endres J; Piktel J; Haqqi TM; Singer NG
J Immunol; 2004 Nov; 173(10):6125-33. PubMed ID: 15528349
[TBL] [Abstract][Full Text] [Related]
16. A sequence conserved between CD5 and CD6 binds an FERM domain and exerts a restraint on T-cell activation.
Breuning J; Brown MH
Immunology; 2019 Mar; 156(3):270-276. PubMed ID: 30460991
[TBL] [Abstract][Full Text] [Related]
17. Identification of residues in CD6 which are critical for ligand binding.
Bodian DL; Skonier JE; Bowen MA; Neubauer M; Siadak AW; Aruffo A; Bajorath J
Biochemistry; 1997 Mar; 36(9):2637-41. PubMed ID: 9054570
[TBL] [Abstract][Full Text] [Related]
18. CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.
Hassan NJ; Simmonds SJ; Clarkson NG; Hanrahan S; Puklavec MJ; Bomb M; Barclay AN; Brown MH
Mol Cell Biol; 2006 Sep; 26(17):6727-38. PubMed ID: 16914752
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of CD6: properties of two distinct epitopes involved in T cell activation.
Swack JA; Gangemi RM; Rudd CE; Morimoto C; Schlossman SF; Romain PL
Mol Immunol; 1989 Nov; 26(11):1037-49. PubMed ID: 2481822
[TBL] [Abstract][Full Text] [Related]
20. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.
Singer NG; Richardson BC; Powers D; Hooper F; Lialios F; Endres J; Bott CM; Fox DA
Immunology; 1996 Aug; 88(4):537-43. PubMed ID: 8881754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
